Page last updated: 2024-11-07

protoberberine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Protoberberine is a naturally occurring alkaloid found in various plants, including Berberis species. It is a precursor to the berberine alkaloid and has been studied for its potential medicinal properties. Protoberberine exhibits a wide range of biological activities, including antimicrobial, anti-inflammatory, and anticancer effects. The synthesis of protoberberine involves the condensation of a substituted benzaldehyde with a substituted phenylacetonitrile followed by a series of reactions. Protoberberine is a subject of research due to its promising pharmacological potential and its role in the biosynthesis of other bioactive alkaloids. Its effects on various biological targets, including enzymes, receptors, and cell signaling pathways, are being investigated to explore its therapeutic applications.'

protoberberine: a benzyltetrahydroisoquinoline derivative that appears as an isoquinoline annelated (adjoined) with a naphthylene; the nitrogen is typically quarternary; nitidine is annelated differently; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID114943
SCHEMBL ID918329
MeSH IDM0053484

Synonyms (11)

Synonym
5,6-dihydrodibenzo(a,g)quinolizinium
protoberberine
19716-69-9
5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium
2,3,11-trimethoxy-5,6,13,13a-tetrahydro-8h-dibenzo(a,g)quinolizine
dibenzo(a,g)quinolizinium, 5,6-dihydro-
UICBHOXXGLYZJH-UHFFFAOYSA-N
5,6-dihydrodibenzo[a,g]quinolizinium
SCHEMBL918329
DTXSID10941470
5,6-dihydroisoquinolino[3,2-a]isoquinolin-7-ium

Research Excerpts

Pharmacokinetics

The pharmacokinetic behavior of five protoberberine-type alkaloids was described in this paper.

ExcerptReferenceRelevance
" The purpose of this study is to compare the pharmacokinetic properties of five protoberberine-type alkaloids (i."( Integrated pharmacokinetics of five protoberberine-type alkaloids in normal and insomnic rats after single and multiple oral administration of Jiao-Tai-Wan.
Cai, H; He, W; Hou, W; Liao, Q; Liu, G; Sun, X; Xie, Z; Zhang, P, 2014
)
0.9
" Plasma samples were collected at different time points to construct pharmacokinetic profiles by plotting drug concentration versus time and estimate pharmacokinetic parameters."( Integrated pharmacokinetics of five protoberberine-type alkaloids in normal and insomnic rats after single and multiple oral administration of Jiao-Tai-Wan.
Cai, H; He, W; Hou, W; Liao, Q; Liu, G; Sun, X; Xie, Z; Zhang, P, 2014
)
0.68
" In the single-dose oral administration, the Cmax and Tmax of five ingredients in insomnic rats had significant differences compared with those of normal rats."( Integrated pharmacokinetics of five protoberberine-type alkaloids in normal and insomnic rats after single and multiple oral administration of Jiao-Tai-Wan.
Cai, H; He, W; Hou, W; Liao, Q; Liu, G; Sun, X; Xie, Z; Zhang, P, 2014
)
0.68
"The pharmacokinetic behavior of five protoberberine-type alkaloids was described in this paper."( Integrated pharmacokinetics of five protoberberine-type alkaloids in normal and insomnic rats after single and multiple oral administration of Jiao-Tai-Wan.
Cai, H; He, W; Hou, W; Liao, Q; Liu, G; Sun, X; Xie, Z; Zhang, P, 2014
)
0.95

Bioavailability

ExcerptReferenceRelevance
" Multiple dosing may improve the absorption of JTW in insomnic rats, which will increase the bioavailability and bring into active role in therapeutical effect."( Integrated pharmacokinetics of five protoberberine-type alkaloids in normal and insomnic rats after single and multiple oral administration of Jiao-Tai-Wan.
Cai, H; He, W; Hou, W; Liao, Q; Liu, G; Sun, X; Xie, Z; Zhang, P, 2014
)
0.68
"The concentration of oligochitosan had different effects on the absorption rate constant (Ka) and apparent permeability coefficient (Peff) of the three active component in rat intestines."( [Study on effect of oligochitosan in promoting intestinal absorption of protoberberine alkaloids in extracts from Corydalis saxicola total alkaloids].
Li, XY; Liu, T; Lu, TL; Shi, YJ; Xie, H; Zhang, XD, 2015
)
0.65

Dosage Studied

ExcerptRelevanceReference
" Multiple dosing may improve the absorption of JTW in insomnic rats, which will increase the bioavailability and bring into active role in therapeutical effect."( Integrated pharmacokinetics of five protoberberine-type alkaloids in normal and insomnic rats after single and multiple oral administration of Jiao-Tai-Wan.
Cai, H; He, W; Hou, W; Liao, Q; Liu, G; Sun, X; Xie, Z; Zhang, P, 2014
)
0.68
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (143)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (6.99)18.7374
1990's10 (6.99)18.2507
2000's46 (32.17)29.6817
2010's55 (38.46)24.3611
2020's22 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.36 (24.57)
Research Supply Index5.00 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index39.97 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (5.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other140 (94.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]